Media Hub

Connecting insights, updates and perspectives from the global life sciences ecosystem.

Scroll More
Connect with Biosparc

2026 © Biosparc

Biosparc Updates

Discover the latest campus developments, tenant announcements, strategic partnerships and major milestones.

More
Biosparc Reaches Topping-Out Milestone as Cross-Border Life Sciences Partnerships Accelerate

Biosparc Reaches Topping-Out Milestone as Cross-Border Life Sciences Partnerships Accelerate

Biosparc Advances China–Singapore Collaboration with New Strategic Partnerships On 20 November 2025, Biosparc’s landmark project in Suzhou Industrial Park reached structural completion and announced a new strategic partnership with True Light PE and ClavystBio, with the goal of strengthening cross-border collaboration in scientific research, translation, and clinical development.

Nov 21, 2025

Innovator Highlights

Explore key moments from ecosystem events, industry dialogues and global collaborations.

Connecting China and Singapore’s Innovation Ecosystems

Connecting China and Singapore’s Innovation Ecosystems

Biosparc Brings Together Singapore’s HSA and Ecosystem Partners to Explore Global Healthcare Collaboration

From “Important Market” to “Critical Innovation Node”

From “Important Market” to “Critical Innovation Node”

How RA Capital Is Reframing China’s Role in the Global Biotech Ecosystem
“Companies Are Bought, Not Sold.”

“Companies Are Bought, Not Sold.”

Rajeev Shah on How Biotech Companies Create Enduring Value
What Does It Take to Build a Truly Great Biotech?

What Does It Take to Build a Truly Great Biotech?

Laura Shawver Shares the Capstan Story in China for the First Time
Eco-event Review4

Eco-event Review4

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...

Adam Guo :
Innovent Biologics experienced a historic year in 2025. This innovative pharmaceutical company, founded in ...
Quin :
Today, BioBAY-based company ICONO announced the completion of a $50 million Series C funding round ...
Eco-event Review5

Eco-event Review5

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Eco-event Review6

Eco-event Review6

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Eco-event Review7

Eco-event Review7

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Eco-event Review8

Eco-event Review8

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Eco-event Review9

Eco-event Review9

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Eco-event Review10

Eco-event Review10

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Eco-event Review11

Eco-event Review11

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Eco-event Review12

Eco-event Review12

An infrastructure designed for the long-term evolution of life sciences. Built around innovation...
Reframing Global Biotech Innovation: Dialogue with RA Capital Management on Venture Building and Cross-Border Acceleration

Reframing Global Biotech Innovation: Dialogue with RA Capital Management on Venture Building and Cross-Border Acceleration

Reframing Global Biotech Innovation: Dialogue with RA Capital Management on Venture Building and Cross-Border Acceleration
Connecting China and Singapore’s Innovation Ecosystems
From “Important Market” to “Critical Innovation Node”
“Companies Are Bought, Not Sold.”
What Does It Take to Build a Truly Great Biotech?
Eco-event Review4
Eco-event Review5
Eco-event Review6
Eco-event Review7
Eco-event Review8
Eco-event Review9
Eco-event Review10
Eco-event Review11
Eco-event Review12
Reframing Global Biotech Innovation: Dialogue with RA Capital Management on Venture Building and Cross-Border Acceleration

Company Milestones

Track important milestones across R&D, clinical development, financing and commercialization.

More

Valued at 3.411 billion yuan ...

An infrastructure designed for the long-term evolution of life sciences. Built around innovation, collaboration ...

JiangSu, Suzhou
Sep 05, 2026

With billions in revenue as its ...

Innovent Biologics experienced a historic year in 2025. This innovative pharmaceutical company, founded in ...

JiangSu, Suzhou
Sep 04, 2026

$50 million! ICONO completes ...

Today, BioBAY-based company ICONO announced the completion of a $50 million Series C funding round ...

JiangSu, Suzhou
Sep 02, 2026

Global Parnterships

Stay informed on developments across our network of investors, research institutions and industry partners.

More
Eco-event Review | Reconstructing ...

Eco-event Review | Reconstructing ...

An infrastructure designed for the long-term evolution of life sciences. Built around innovation, collaboration...

Sep 05, 2026
Bio Insights | Trends of ...

Bio Insights | Trends of ...

An infrastructure designed for the long-term evolution of life sciences. Built around innovation, collaboration...

Sep 04, 2026
Sino-Singapore Ophthalmology ...

Sino-Singapore Ophthalmology ...

An infrastructure designed for the long-term evolution of life sciences. Built around innovation, collaboration...

Sep 01, 2026

Stay Connected

Receive the latest updates, event invitations and ecosystem insights from Biosparc.

Subscribe for Updates